Joel Beatty
Stock Analyst at Baird
(4.58)
# 225
Out of 5,157 analysts
211
Total ratings
51.2%
Success rate
34.13%
Average return
Main Sectors:
Stocks Rated by Joel Beatty
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNTH Dianthus Therapeutics | Maintains: Outperform | $67 → $132 | $86.92 | +51.86% | 4 | Mar 10, 2026 | |
| CTNM Contineum Therapeutics | Maintains: Outperform | $14 → $20 | $13.41 | +49.14% | 4 | Mar 6, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Outperform | $275 → $433 | $309.91 | +39.72% | 3 | Feb 20, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Outperform | $72 → $47 | $22.84 | +105.78% | 5 | Dec 30, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Outperform | $160 → $209 | $185.93 | +12.41% | 5 | Nov 18, 2025 | |
| ELF e.l.f. Beauty | Maintains: Outperform | $145 → $125 | $80.49 | +55.30% | 9 | Nov 6, 2025 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Outperform | $10 → $19 | $14.98 | +26.84% | 5 | Oct 16, 2025 | |
| LRMR Larimar Therapeutics | Maintains: Outperform | $10 → $7 | $5.61 | +24.78% | 3 | Sep 30, 2025 | |
| EDIT Editas Medicine | Maintains: Outperform | $4 → $6 | $2.64 | +127.27% | 5 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Neutral | $7 → $9 | $36.68 | -75.46% | 6 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $31 | $22.54 | +37.53% | 4 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $38 → $24 | $23.07 | +4.03% | 5 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $680 | $742.79 | -8.45% | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $29 | $21.43 | +35.32% | 2 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $66 | $68.56 | -3.73% | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $160 → $162 | $166.34 | -2.61% | 5 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $38 → $41 | $27.74 | +47.80% | 3 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $32 | $24.77 | +29.19% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $75 | $79.63 | -5.81% | 1 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $7 | $2.76 | +153.62% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $65 | $60.89 | +6.75% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $540 → $240 | $0.36 | +66,566.67% | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $4.5 | $1.63 | +176.07% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $25 | $15.90 | +57.23% | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $28 | $24.16 | +15.89% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.28 | +1,150.00% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4 → $1.25 | $1.47 | -14.97% | 2 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $44 | $1.39 | +3,065.47% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $58 | $59.20 | -2.03% | 6 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $24 | $34.74 | -30.92% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 | $7.62 | +136.22% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 → $6 | $2.02 | +197.03% | 2 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $36 → $28 | $9.88 | +183.40% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $170 → $175 | $322.38 | -45.72% | 2 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 | $9.56 | +46.44% | 8 | Jan 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $108 | $17.66 | +511.55% | 10 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $78 | $75.66 | +3.09% | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $100 | $23.54 | +324.81% | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $120 | $15.97 | +651.64% | 14 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $450 | $4.66 | +9,556.65% | 2 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $2.70 | - | 12 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $15 | $10.69 | +40.32% | 11 | Sep 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $14 → $11 | $12.79 | -17.90% | 8 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2,400 → $1,200 | $0.38 | +318,964.08% | 2 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $19 | $9.26 | +105.18% | 3 | Nov 10, 2017 |
Dianthus Therapeutics
Mar 10, 2026
Maintains: Outperform
Price Target: $67 → $132
Current: $86.92
Upside: +51.86%
Contineum Therapeutics
Mar 6, 2026
Maintains: Outperform
Price Target: $14 → $20
Current: $13.41
Upside: +49.14%
Praxis Precision Medicines
Feb 20, 2026
Maintains: Outperform
Price Target: $275 → $433
Current: $309.91
Upside: +39.72%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Outperform
Price Target: $72 → $47
Current: $22.84
Upside: +105.78%
Jazz Pharmaceuticals
Nov 18, 2025
Maintains: Outperform
Price Target: $160 → $209
Current: $185.93
Upside: +12.41%
e.l.f. Beauty
Nov 6, 2025
Maintains: Outperform
Price Target: $145 → $125
Current: $80.49
Upside: +55.30%
Amylyx Pharmaceuticals
Oct 16, 2025
Maintains: Outperform
Price Target: $10 → $19
Current: $14.98
Upside: +26.84%
Larimar Therapeutics
Sep 30, 2025
Maintains: Outperform
Price Target: $10 → $7
Current: $5.61
Upside: +24.78%
Editas Medicine
Aug 13, 2025
Maintains: Outperform
Price Target: $4 → $6
Current: $2.64
Upside: +127.27%
Cogent Biosciences
Jul 8, 2025
Maintains: Neutral
Price Target: $7 → $9
Current: $36.68
Upside: -75.46%
May 19, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $22.54
Upside: +37.53%
May 16, 2025
Downgrades: Neutral
Price Target: $38 → $24
Current: $23.07
Upside: +4.03%
May 13, 2025
Upgrades: Outperform
Price Target: $680
Current: $742.79
Upside: -8.45%
May 8, 2025
Maintains: Outperform
Price Target: $30 → $29
Current: $21.43
Upside: +35.32%
May 7, 2025
Maintains: Outperform
Price Target: $70 → $66
Current: $68.56
Upside: -3.73%
May 6, 2025
Maintains: Outperform
Price Target: $160 → $162
Current: $166.34
Upside: -2.61%
May 2, 2025
Maintains: Outperform
Price Target: $38 → $41
Current: $27.74
Upside: +47.80%
Mar 3, 2025
Maintains: Outperform
Price Target: $28 → $32
Current: $24.77
Upside: +29.19%
Nov 25, 2024
Initiates: Outperform
Price Target: $75
Current: $79.63
Upside: -5.81%
Nov 15, 2024
Maintains: Outperform
Price Target: $6 → $7
Current: $2.76
Upside: +153.62%
Oct 30, 2024
Maintains: Neutral
Price Target: $72 → $65
Current: $60.89
Upside: +6.75%
May 15, 2024
Maintains: Outperform
Price Target: $540 → $240
Current: $0.36
Upside: +66,566.67%
Apr 30, 2024
Downgrades: Neutral
Price Target: $4.5
Current: $1.63
Upside: +176.07%
Apr 11, 2024
Maintains: Outperform
Price Target: $24 → $25
Current: $15.90
Upside: +57.23%
Oct 3, 2023
Maintains: Outperform
Price Target: $32 → $28
Current: $24.16
Upside: +15.89%
Jun 1, 2023
Initiates: Outperform
Price Target: $16
Current: $1.28
Upside: +1,150.00%
May 2, 2023
Maintains: Outperform
Price Target: $4 → $1.25
Current: $1.47
Upside: -14.97%
Apr 13, 2023
Initiates: Outperform
Price Target: $44
Current: $1.39
Upside: +3,065.47%
Feb 7, 2023
Maintains: Outperform
Price Target: $60 → $58
Current: $59.20
Upside: -2.03%
Nov 18, 2022
Maintains: Outperform
Price Target: $18 → $24
Current: $34.74
Upside: -30.92%
Nov 10, 2022
Downgrades: Underperform
Price Target: $18
Current: $7.62
Upside: +136.22%
Aug 29, 2022
Maintains: Outperform
Price Target: $9 → $6
Current: $2.02
Upside: +197.03%
Mar 3, 2022
Upgrades: Neutral
Price Target: $36 → $28
Current: $9.88
Upside: +183.40%
Feb 12, 2021
Downgrades: Neutral
Price Target: $170 → $175
Current: $322.38
Upside: -45.72%
Jan 14, 2021
Downgrades: Neutral
Price Target: $14
Current: $9.56
Upside: +46.44%
Jan 12, 2021
Downgrades: Neutral
Price Target: $108
Current: $17.66
Upside: +511.55%
Aug 10, 2020
Maintains: Buy
Price Target: $80 → $78
Current: $75.66
Upside: +3.09%
Apr 6, 2020
Maintains: Buy
Price Target: $140 → $100
Current: $23.54
Upside: +324.81%
Apr 1, 2020
Maintains: Buy
Price Target: $480 → $120
Current: $15.97
Upside: +651.64%
Mar 26, 2020
Maintains: Buy
Price Target: $480 → $450
Current: $4.66
Upside: +9,556.65%
Mar 17, 2020
Upgrades: Buy
Price Target: n/a
Current: $2.70
Upside: -
Sep 24, 2019
Maintains: Buy
Price Target: $19 → $15
Current: $10.69
Upside: +40.32%
Aug 17, 2018
Upgrades: Neutral
Price Target: $14 → $11
Current: $12.79
Upside: -17.90%
Aug 17, 2018
Maintains: Neutral
Price Target: $2,400 → $1,200
Current: $0.38
Upside: +318,964.08%
Nov 10, 2017
Maintains: Buy
Price Target: $15 → $19
Current: $9.26
Upside: +105.18%